Background: Plasma cells (PCs) are terminally differentiated B-lymphocytes producing antibodies. In coeliac disease (CeD) there is increased density of PCs in the small-intestinal lesion. Many of these PCs produce disease-specific autoantibodies targeting transglutaminase 2 (TG2). Objective: The plasmacytosis of CeD motivated us to study the transcriptional programme of PCs from coeliac gut lesions. Methods: RNA-seq was performed on the PCs of CeD patients and disease controls, being specific or non-specific for TG2. Results: Being antibody-producing cells, 67% of the PCs' transcript was aligned to immunoglobulin genes. Strikingly, genes encoding ligands and receptors of chemokines and cytokines were abundant. Higher transcript levels of genes associated with cell activation and immune responses were observed in PCs of CeD patients compared to controls. TG2-specific compared to non-TG2 specific PCs expressed increased levels of CXCR3, CXCL10 and interleukin-15; factors that have been implicated in the pathogenesis of CeD yet with production attributed to other cells than PCs. The presence of transcripts of HLA class II and T-cell co-stimulatory molecules suggests that PCs may serve as antigen-presenting cells for CD4 þ helper T cells. Conclusions: Our findings shed new light on the biology of intestinal PCs, implicating functions that go beyond the production of immunoglobulins.
Introduction
Plasma cells (PCs) are highly specialised antibody-producing cells, mostly localised in special survival niches in the bone marrow and at mucosal tissues. In coeliac disease (CeD), a gluten-mediated enteropathy characterised by villous atrophy and malabsorption, and a two-to three-fold increased density of PCs in the lamina propria are the hallmarks of active disease. 1, 2 A substantial proportion of the PCs in CeD gut lesions is specific for the disease-associated antigens transglutaminase 2 (TG2) and deamidated gluten peptides. 3, 4 A strict avoidance of gluten from the diet normally results in the recovery of the villus structures and normalisation of PC density.
Little is known about the contribution of PCs to the generation of coeliac lesions and their immunological functions. Recent reports, however, have indicated that PCs exert functions that go beyond antibody production. Distinct functions were attributed to PCs based on their cytokine profile. 5 Malignant plasma cells were demonstrated to produce cytokines and chemokines, and to activate cluster of differentiation (CD)4 þ helper T cells. 6 Expression of HLA-DR, HLA-DQ, and the co-stimulatory molecules CD40, CD80 and CD86 by PCs were also reported. [6] [7] [8] [9] [10] Such functions would be particularly notable in conditions where PCs are prevalent, for example in CeD, where production of inflammatory mediators may have significant effects due to their vast numbers.
To understand whether and how PCs may contribute to intestinal inflammation, we characterised the transcriptional profiles of the small-intestinal PCs of disease controls and patients with active CeD. We demonstrate that gut PCs express transcripts of genes that encode for inflammatory mediators and receptors, co-stimulatory molecules and HLA class II. Our findings suggest that PCs have the ability to respond to external stimuli via their surface receptors and thus interact with other immune cells, in particular, CD4 þ T cells.
Methods

Study material
Seven CeD patients with active disease and four disease controls were enrolled in this study ( Table 1) . All subjects visited the gastroenterology unit for clinical assessment. CeD was diagnosed according to the guidelines of the British Society of Gastroenterology. 11 The disease control subjects were examined due to irritable bowel syndrome and histological assessment of routine biopsies revealed no signs of inflammation. Single cell suspensions were prepared from small-intestinal biopsies as described. 12 All other methodological procedures are available as supplementary information.
Results
RNA-seq libraries
RNA-seq was performed on sorted intestinal IgA PCs from disease controls (hereafter referred to as DC-PCs), and the PCs of CeD patients, being specific or not specific for the autoantigen TG2 (hereafter TG2-PCs and non-TG2-PCs, respectively). The library sizes ranged from 36-67 million read pairs per sample. Around 78-82% of the total reads were mapped to the known transcripts annotated in GENCODE GRCh38.p7. In line with previous observations 13 61-67% of the mappable reads were mapped to immunoglobulin (Ig) genes. Following filtration of Ig-mapped reads, the libraries varied from 12-25 million reads. Based on a conservative definition, 14 around 45% of the total known protein-coding genes (>10,000 genes) were considered to be 'active' in each of the Ig-filtered libraries ( Supplementary Table 1 ). To examine the purity of sorted PCs we searched for genes that were specific for T cells, monocyte, dendritic cells, eosinophils and stromal cells; all were absent from the data (Figure 1 ).
Transcriptional profiles of intestinal IgA PCs
To survey the transcriptional programme of intestinal IgA PCs (other than Ig-encoding transcripts), we looked into the biological functions ascribed to the most abundantly expressed genes (n ¼ 3000) in (i) DC-PCs, (ii) TG2-PCs and (iii) non-TG2-PCs. Notably, each of the PC groups expressed the same set of top 3000 genes, including known PC transcripts such as Blimp-1, syndecan-1, XBP1, IRF4, BCMA, TACI, CD27 and CD38. B-cell specific genes that are repressed in PCs such as CD20, PAX5 and BACH2
were not observed. The 50 most abundantly expressed genes across the three groups are depicted in Figure 2a and Supplementary Figure 1 .
Gene ontology (GO) categorisation of the top 3000 most highly expressed genes revealed that the core transcriptional programme of intestinal IgA PCs extends beyond antibody production and secretion. Specifically, genes related to immunological pathways, stimulus response, cellular processes, signalling, and cell proliferation were enriched (Figure 2b ). Several GO terms related to the protein machinery (i.e. antibody production) of PCs were also enriched. Functions related to RNA and protein anabolism/ catabolism, ribosome biogenesis, protein folding, biosynthesis of macromolecule and protein localisation were prominent.
Dissection of PC transcripts encoding for immunological mediators and receptors
The GO analysis demonstrated that immunological pathways are in the core of the transcriptional programmes of gut IgA PCs. Hence, the transcription patterns of genes related to (i) cytokines and cytokine receptors, (ii) chemokines and their receptors, (iii) antigen presentation and (iv) co-stimulatory molecules were closely examined.
(i) Cytokines and cytokine receptors: IL-16, IL-15 and TGFB1 were highly abundant, whereas IL-6 and IL-32 were expressed at lower levels ( Figure 3a) . Four TNF superfamily genes were expressed: TNFSF9 and TNFSF10 that induce T-cell activation and apoptosis, respectively; TNFSF13 (APRIL) and TNFSF13B (BAFF) that are essential for PCs development. IL-12A and IL-23A were also expressed; however, the transcript for their common p40 subunit was not detected.
All subunits to form functional cytokine receptors of IL-5, IL-6, IL-10, IL-17A, IL-17F, IL-21 and IL-27 were expressed (Figure 3a) , as well as the paired receptor genes for IFNa (IFNAR1/2), IFNg (IFNGR1/2), IFN (IFNLR1 and IL10RB) and TGFBR1/R2. TACI, BAFF-R and BCMA (i.e. TNFRSF13B, TNFRSF13C and TNFRSF17, respectively) known to be essential for PCs differentiation and survival were abundant. TXNDC5  TSC22D3  HERPUD1  EEF1A1  MT-CYB  DUSP1  PIM2  HSPA5 MT
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Non TG2-PCs (ii) Chemokines and chemokine receptors: Chemoattractant genes for T cells, monocytes and macrophages such as CCL3, CCL4, CCL4L2, CXCL10 and CXCL16 were found. mRNA for chemokine receptors responding in an inflammatory environment such as CCR2, CCR10 and CXCR3 were also detected ( Figure 3a ). (iii) Antigen presentation: As expected, transcripts for HLA class I molecules were abundantly expressed.
Remarkably, genes encoded to HLA class II molecules were also found consistently across all PCs samples (Figure 3b ). The MHC class II antigenassociated invariant chain (CD74) was among the top 50 expressed genes. (iv) Co-stimulatory molecules: Genes that aid crosstalk with T cells were expressed. Of particular note were TNFSF9 (4-1BBL) that interacts with 4-1BB; ICOSL, CD86; CD48 and CD58 that interact with CD2; CD40 that interacts with CD40L; and ICAM1/2/3/4 that interact with LFA1 on T cells. MIC-A and MIC-B that react with NKGTD and NKGTA that are expressed on NK cells, intraepithelial T cells and gdT cells were also detected ( Figure 3c ).
Supplementary Figure 2 depicts the individual variation of immunological mediators and receptors expressed by PCs.
PCs of CeD patients exhibit an increased inflammatory profile
Next, we compared the transcriptional profiles (all expressed genes) of PCs of the disease control and CeD patients. Differential expression (DE) analysis was performed for DC-PCs vs. non-TG2-PCs and DC-PCs vs. TG2-PCs. A hundred and forty genes had increased activity in both non-TG2-PCs and TG2-PCs in comparison with DC-PCs (Figure 4a , Supplementary  Figure 3 and Supplementary Table 2 ). GO categorisation of these 141 DE genes implied that PCs from patients were at higher activation levels relative to DC-PCs ( Figure 4b ). Such genes are known to participate in cellular processes such as (i) response to stimulus, (ii) cell activation, (iii) cell surface receptor signalling and others. Of particular note are genes that were grouped under 'immune effector process' and 'lymphocyte chemotaxis' (such as ADAM10, GPR183, CXCL10, and HSD3B7), which play a pivotal role in recruiting immune cells to an inflammatory site.
TG2-PCs exhibit increased expression of genes related to T-cell activation and chemotaxis
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Discussion
In this work, we analysed the transcriptomic profile of intestinal IgA PCs. Being highly specialised antibodyproducing cells, PCs are not considered to be involved in immunoregulatory circuits. Our findings challenge this notion. We found expression of genes that play crucial roles in various immune system processes, thus suggesting that PCs have the ability to respond to stimuli and to interact with their surrounding environment. Interestingly, in the inflamed gut, the PCs showed higher transcript levels of inflammatory mediators and receptors. The expression of gene encoding for cytokines, chemokines and their receptors by PCs suggests a crosstalk with other immune cells, primarily T cells. Of particular interest are the expressions of IL-15 and IL-16; the latter is the ligand for CD4 (and CD9). It attracts and activates CD4 þ T cells, [15] [16] [17] upregulates CD25 and CD122 and thus primes and facilitates their responsiveness to IL-2 and IL-15. 18 Elevated levels of IL-15 have been reported in CeD 19, 20 as well as in inflammatory bowel disease. 21 This cytokine supports the survival and proliferation of cytotoxic intraepithelial lymphocytes (IELs), which can directly damage epithelial cells and lead to tissue remodelling in CeD. 22 IL-15 is   12   14   16   10  8  6  4   ATF5  AMMECR1L  SLC7A11  PLCB2  EPG5  S100A4  PALD1  HIST1H2AG  GRINA  MYL2  PLAC8  TRIM25  IGLL1  HSBP1L1  KIAA0907  FCHSD1  ZNF83  MALL  EZH2  IL5RA  EAF1  CYB5R2  CES4A  EXD3  MPV17L  LCMT2  UEVLD  LPIN2  FANCE  FLVCR1  ESAM  PPP1R2P9  MLLT1  TLR6  CCDC169  ANKRD53  KLHL26  PRSS51  VPREB3  EMP2  KIAA2022  FAM50B  ZEB2  ZNF530  COCH  PAX5  TREML2  VIL1  PHLDA3  PBLD  MEIS1  ATP8B1  UNC13C  TPSAB1  FN1  CLU   TG2 TMEM154  GPR89B  GBP5  SCYL3  CNTRL  CD99  FBXW2  IL15  FAM208B  LAT2  CTGF  PGPEP1  PLTP  HIST1H2BC  WDR24  ANK1B1  MIXL1  CLN6  TMEM64  TBXAS1  YBX3  IQCG  SULF2  CLDN3  TIAM2  DEPTOR  COX20  RGPD2  RAB5C  C10orf10  MGMT  FAM118A  CCDC14  KPNA5  LCP1  APH1A  ERLIN2  CXCR3  MRPS23  B3GNT9  CCDC189  GBP2  TEX14  HSPA14  SPN  PLA2G2D  CLEC2D  PAWR  ANKH  TNFSF9  TMEM110  CEP83  DD12  LRRC24  WDR81  GADD45G  KMO   JUN  ACADVL  RPS3  CD27  MT-ATP8  GOLGB1  KLF2  QPCT  STK17B  OGT  AC141272.1  MDM2  IARS  EHMT1  MAN1A2  ALOX5  CCDC50  NPIPB5  TUBGCP6  ANKRD10  HIST1H4C  SMCHD1  HIPK2  IFRD1  PCF11  PTPRC  CLEC2B  MAP3K13  PHACTR1  NPEPL1  TNFRSF4  RASD1  ZDHHC18  CTSW  ITPRIP  KLHL5  YY1  PERP  N4BP2  CWC25  ETFDH  IP6K2  DDX42  PAPD7  OGFOD3  TSPAN7  HLA-DQA1  CXCL10  DUSP26  RNASEH2C  METTL17  RCN3  TMEM156  ABCA7  CAPG therefore thought to have a central role in the pathogenesis of CeD, with epithelial cells and lamina propria dendritic cells being its main sources. 23, 24 Here, we demonstrated that intestinal PCs express high levels of IL-15 and IL-15RA transcripts. IL-15 functions chiefly via cell-to-cell contact (i.e. trans presentation) by which the membrane bound IL-15:IL-15Ra complex is presented to the interacting cell. Co-expression of IL-15 and IL-15RA suggests that PCs have the ability to activate CD4 þ T cells, IELs and CTLs; all T-cell subsets being involved in gut inflammation and shaping of the coeliac lesion. CXCL9, CXCL10 and CXCL11 being ligands for CXCR3 attract cells to inflammatory sites. The expression of CXCL10 and CXCL11 has been shown to increase in duodenal biopsies of untreated CeD patients, and PCs and enterocytes were identified as CXCL10-producing cells. 25 Our data support these findings and further demonstrate that autoreactive TG2-PCs express high levels of CXCL10 and CXCR3. Thus TG2-PCs and also non-TG2-PCs in CeD directly contribute to the recruitment of CXCR3-expressing cells such as Th1 cells, IELs, gdT cells, monocytes, PCs, and other immune cells that take part in ongoing gut inflammation. IL-15, IFNa, and IFNg that are found at increased levels in the coeliac lesion, are known to induce the production of CXCL10. 26 Both IFN receptors are expressed by PCs; it is thus conceivable that the elevated levels of CXCL10 expressed by PCs are due to the effect of these cytokines. Additionally, PCs express CCL3, CCL4, CCL4L2, CCL25 and CXCL16. Taken as a whole, the vast expression of chemokine genes suggests that PCs contribute to the recruitment of immune cells to gut inflammatory sites.
The expression of HLA class II molecules is thought to be silenced during PC differentiation. Several studies, however, reported various levels of surface expression of HLA class II molecules as well as co-stimulatory molecules such as CD86 on PCs. 9, 10 We have shown that PCs express HLA class II transcripts as well as HLA-DM and CD74. In line with Ellyard et al., 9 we found CD86 (but not CD80) to be expressed, thus suggesting that intestinal PCs can function as competent antigen-presenting cells (APCs) to CD4 þ T cells. Intestinal IgM and IgA PCs maintain expression of Ig surface receptors. 3, 27 Being antigen-specific, PCs, via their B cell receptors (BCRs), can internalise antigen and thereafter load HLA class II molecules with peptides from the BCR-targeted antigen. Even though HLA class II expression on PCs may be low, the numbers of a specific peptide HLA II complex, might be sufficient to stimulate cognate activation of T cells. Intriguingly, by employing a monoclonal antibody specific for an HLA-DQ:gluten-peptide complex (i.e. HLA-DQ2.5:DQ2.5-glia-a1a), PCs were shown to be the main cells presenting a gluten epitope in untreated CeD patients. 28 Functional testing of gut PCs as APCs for CD4 þ T cells in general, and gluten-specific CeD CD4 þ T cells in particular, should thus be a priority in future studies.
Here, we have shown that PCs express genes implicated in cellular and immunological functions that expand beyond their role as antibody-secreting cells. PCs have the potential to produce inflammatory cytokines and chemokines and respond to environmental cues via designated receptors. They may have an intimate cross-talk with CD4 þ T cells that include chemotaxis, activation, and antigen presentation. Additional studies are needed to understand the function of PCs and their role in gut inflammation.
